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Abstract
Purpose Patient-reported outcome measurement (PROM)
plays an increasing role in palliative and end-of-life
(EOL) care but their use in EOL care and research remains
varied and inconsistent. We aimed to facilitate pan-European
collaboration to improve PROMs in palliative and EOL care
and research.
Methods The study includes a workshop with experts expe-
rienced in using PROMs in clinical care and research from
Europe, North America, and Africa. Information from
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presentations, and plenary and group discussions was ana-
lysed using content analysis for extracting the main themes.
Results Thirty-two professionals from 15 countries and eight
different professional backgrounds participated in the work-
shop. The discussion identified: 1) the need for standardisation
with improvement of existing PROMs, e.g., with a modular
system and an optional item pool; 2) the aspects of further
development with a multi-professional approach taking into
account cultural sensitivity especially for translated versions;
and 3) the need for guidance, training, and resources. An
international network for sharing concepts, experiences, and
solutions could enhance these steps of further development.
Conclusion PROMs must be based on rigorous scientific
methods and respond to patient complexity. Coordinated
pan-European collaboration including researchers and clini-
cians is required to develop and attain quality care and
systematic research in outcome measurement in palliative
and EOL care.
Keywords Outcome measurement . PROM . Cancer .
Palliative care . End-of-life care . Research . Europe
Introduction
Patient-reported outcome measurement (PROMs) play an in-
creasing role in palliative and end-of-life (EOL) care but their
use in EOL care and research remains varied and inconsistent,
with often diverse measures being used once or twice only
[1–3]. EOL care faces various complexities influencing the
measurement of outcomes: (i) patients may report multiple
symptoms rather than one problem, (ii) problems and symp-
toms are often complex (e.g., fatigue and spiritual problems),
and (iii) patients go through different stages in their disease
trajectory including the experience of deterioration at the end
of life, with changing priorities and reduced physical and
cognitive function [4]. With an increasing ageing European
population and a growing number of patients with cancer and
other chronic conditions, there is an urgent need for interna-
tional exchange and collaboration to identify barriers and
priorities and to develop solutions, best science, and outcomes
for European citizens. This could lead to an agreement on a
standard core set of outcome measures to enable robust com-
parative research [5].
Our aim was to facilitate pan-European collaboration to
improve PROMs in palliative and EOL care and research. The
objectives were:
1. To engage experts in sharing experiences and to identify
the best practice of PROMuse in clinical care and research;
2. To develop a platform for the development of resources
and support for those who use or want to use PROMs; and
3. To identify further direction and priorities regarding the
development of PROMs.
Methods
An international 2-dayworkshopwas held in Germany (Berlin)
in March 2010 led by the German Association for Palliative
Medicine (Deutsche Gesellschaft für Palliativmedizin) as part
of a large European Commission funded project titled:
PRISMA (Reflecting the Positive Diversities of European
Priorities for Research and Measurement in End of Life Care).
PRISMA aims to inform clinical practice and harmonise re-
search in EOL cancer care across Europe through comparison
and exchange of approaches and experiences in measurement
and research priorities [6, 7].
Workshop
The workshop addressed: 1) experiences of PROMs in pallia-
tive and EOL care and research, 2) general issues of PROMs
(cultural and language translational aspects), and 3) future of
PROMs. We focused on PROMs that assess patients’ needs,
quality of life, quality of care, and those that focus on multiple
symptoms within one measure (rather than measures that focus
on one symptom only). Short presentations provided con-
densed input to initiate further discussion. Speakers were se-
lected based on expertise and research experiences. Emerging
topics were discussed in parallel group work at the end of each
day. Notes were taken from all sessions. All presentations and
discussions were audio-recorded for further analysis.
Sampling
To identify participants, a purposive sample was used to
achieve diversity regarding country and profession to enable
sharing of diverse experiences of using tools in palliative and
EOL care [8]. An ‘expert’was defined as having at least 6 years
of experiences in use of PROMs either in clinical care or
research in palliative and EOL care. These criteria were used
to draw a sample from the respondents of an international
online survey on outcomemeasures in palliative care of interest
in the workshop [9]. In addition, experts were located through a
literature search on publications on outcome measures in pal-
liative and EOL care and invited for participation.
Data analysis
For the purpose of analysis, all information shared during the
workshop was used including presentations, minutes from
group discussions, plenary meetings, and audio recordings
of sessions. Informed consent was obtained from all partic-
ipants for analysis of this material. Content analysis (analytical
hierarchy including descriptive and analytic accounts) was
used for extracting the main themes and statements in order
to summarise the results [8]. Analysis was conducted by two
well-trained researchers with expertise in qualitative research.
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Differences in coding were discussed, and consensus was
achieved with a third reviewer [8]. Finally, the results were
sent to all speakers of the workshop, comments were dis-
cussed, and integrated into the final results.
Results
Workshop participants
Invited participants (32/43) from various backgrounds (16
physicians, five social workers/sociologists, four psychologists,
three nurses, and one each of music therapist, statistician,
anthropologist, and health economist) and 15 different
countries (eight English, six German, three Portuguese, three
Italian, two Polish, and one each from Belgium, Canada,
Georgia, Hungary, Ireland, Netherlands, Norway, Spain, Swit-
zerland, and Uganda) participated. All had experiences in using
PROMs in EOL care either in clinical practice, audit, and
research or a combination of these.
Specific aspects of PROMs in palliative and EOL care
Workshop participants noted the lack of a clear roadmap or
uniform approach to measuring outcomes in palliative and
EOL care and the absence of standardisation hindering com-
parisons (e.g., between different patient groups or across
countries). Furthermore, some of the key terms in palliative
and EOL care such as quality of life, dignity, resilience, and
spirituality are not easily understood or clearly defined making
outcome measurement in these areas even more challenging.
Regardless, EOL care providers must prove the quality of their
care and, therefore, need valid and reliable measures. Also,
PROMs play an important role for the use of quality indicators
in EOL care in order to monitor and improve care [10].
The African participant reported about the enthusiasm,
commitment, and success when incorporating a new PROM
in clinical practice in Africa. The evaluation of the implemen-
tation process was also a useful example for change manage-
ment [11, 12].
Future development of PROMs
The following topics evolved from the discussions during the
workshop.
Guidance, training, and resources
A lack of guidance on how to choose PROMs and information
about existing and validated measures was identified. There
was also an urgent need for training and support for the use of
PROMs in palliative and EOL care and research. This included
assistance beginning with implementation through to analyses
and interpretation of findings. Materials should be provided
online, in print versions, and face-to-face (e.g., courses or
summer schools).
The ‘ideal measure’
Participants agreed that an ‘ideal measure’ in palliative care
would contain six to ten questions; cover all (complex) aspects
and dimensions of palliative and EOL care; be easy to use and
brief to administer; understandable for cognitively impaired
patients; non-burdensome to patients, carers and staff; and
produce relevant and comparable results. All agreed that this
‘ideal measure’ does not exist and might not be able to be
developed in the complex field of palliative and EOL care.
However, there is a need to improve existing PROMs based
on scientifically rigorous criteria to allow for comparisons
across different studies and adaptation to the cultural diversity
and local specificities. The development of a modular system
with a set of core questions covering the main dimensions of
palliative care and an optional item pool with additional dimen-
sions and symptoms was proposed. Although this option was
discussed controversially because of several disadvantages
with loss of standardisation and validation difficulties, it was
deemed feasible to balance practicability, quality, standardisa-
tion, and flexibility.
Translating PROMs with adaptation to cultural diversities
Translation includes not only the instrumental adaptation of
objective information but involves a process of conveying
meanings and concepts to a completely different culture. To
assure this, members of the cultural groups studied should be
involved in the translation process, and pilot testing with cog-
nitive interviews incorporating think-aloud technique was sug-
gested to get a balance of accuracy and relevance in the
translation process [13].
Importance of involving nurses' views and competencies
For a better understanding of the day-to-day problems and
quality improvement purposes, nurses need to be involved in
the development and implementation process of PROMs.
Inclusive participation and ownership will improve the rele-
vance and acceptance of PROMs in clinical care and help
overcome problems and barriers (e.g., gatekeeping and organ-
isational concerns). These considerations also apply to other
health professionals, e.g., psychologists.
International collaboration
An international network for sharing concepts, experiences,
and solutions could enhance the required balance between
standardisation and diversity, and develop recommendations
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based on an international consensus to improve high quality of
care. The collaborative project PRISMA could be a good
platform to launch this network and develop an action plan
to keep and enhance the current momentum. Involvement of
key bodies such as the European Association for Palliative
Care was deemed important to this process. This process
should include external expertise and needs substantial fund-
ing. As a result of the discussion, a number of recommenda-
tions were formulated to inform future actions (Table 1).
Discussion
Growing evidence shows that the use of PROMs improves
patient well-being and communication between patients and
clinicians [14]. To facilitate pan-European collaboration in
PROM in palliative and EOL care and research, we invited
experts in the field to discuss challenges and barriers and to
formulate recommendations for the future development of
PROMs. Huge efforts have been undertaken in scale devel-
opment within palliative care leading to a large number of
tools, and some work exists on implementation of outcome
measures into clinical practice [15, 16]. However, most are
used inconsistently and a lack of coordination and standard-
isation hinders comparison of patient groups across studies
and countries and precludes an appropriate definition of the
palliative care patient population to determine which tools are
useful with which population [16, 17].
Various initiatives exist in oncology defining the impor-
tance of PROMs in cancer research and practice (e.g.,
Patient-Reported Outcome Measurement Information System
(PROMIS), Common Terminology Criteria for Adverse
Events (CTCAE), and International Society of Pharmacoeco-
nomics and Outcomes (ISPOR)) but the focus is more on
active cancer treatment including documentation of adverse
effects rather than the end of life. Although PROMs have been
increasingly included in clinical trials of cancer treatment,
survival or surrogates are often used as the main outcome
variables rather than symptom- or health-related quality of life
(HRQOL) assessment. Taking into account these challenges,
the National Cancer Institute in the US has established a
steering committee for symptom management and HRQOL
assessment to improve the development, use, and implemen-
tation of PROMs in clinical care and clinical trials [18]. Our
results also highlight the importance of multiprofessional
outcome measurement initiatives within Europe through the
integration of nurses within development and implementation
processes. Previous findings have shown that nurses and
physicians share similar views regarding outcome measure-
ment in EOL care and, therefore, multiprofessional initiatives
may be possible [19].
For an appropriate balance between standardisation and
flexibility, the development of item banks (e.g., for psycho-
logical distress in cancer) or the cancer sites' specific HRQOL
measures by the EORTC might be good examples to follow
[5, 20]. Cultural competences and the need for adaptation to
local differences might be more relevant to palliative and EOL
care because of the wide scope these areas of care cover and
the importance of culture when coping with a diagnosis of
incurable illness or facing death. Therefore, more attention to
developing culturally sensitive PROMs in palliative and EOL
care is recommended. In addition, the focus of the discussions
Table 1 Recommendations of the international workshop for the future improvement of patient-reported outcome measures (PROMs)
Need for standardization 1. Given the high number of different tools with various validation qualities, there is need for standardization and
agreement of a core set of tools in palliative and EOL care
2. Standardization should be based on scientific rigorous criteria rather than consensus only
3. Standardization needs to be balanced with diversity and flexibility
Development, validation and
adaption
4. Further development of PROMs needs a multiprofessional approach to include the different
competencies of all professional groups in palliative and EOL care
5. Future development of PROMs needs to focus on cultural sensitivity and attention to local differences
6. Translation of PROMs needs to extend beyond a merely linguistic exercise to a broader and
rigorous approach taking inter-cultural differences into account
Guidance and training 7. Guidance needs to be developed and should include:
• The setting in which the measure is to be used (e.g. hospital ward and home)
• The purpose of PROMs (e.g., screening, assessment and quality assurance)
• The background, context and training of professional administering the measure (e.g., nurses and physicians)
• How PROM findings will be used (e.g., care evaluation, communication aid amongst
service users and clinicians)
8. Training is required in relation to:
• Implementation of PROMs in daily routine of an organization or clinical team
• Strategies to manage and overcome barriers and staff reluctance regarding the use of PROMs
• Analysis and interpretation of PROM data
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so far has been on the gold standard measure, i.e., PROMs,
rather than proxy measures. It is acknowledged that this also
needs to be considered in the future.
The creation of an international network regarding out-
come measures in palliative and EOL care has the potential
to encounter these challenges in order to improve the quality
and outcome of clinical care. Although the workshop was
facilitated by the European coordination project PRISMA,
we invited participants from Eastern Europe, Canada, and
Africa to strengthen international links. This placed the
discussions in a collaborative and international framework
that allowed formulating an action plan on further develop-
ment and support of PROMs in palliative and EOL care
across Europe [3]. The findings and conclusions of the
workshop could have been strengthened by a formal con-
sensus process (e.g., Delphi) based upon the qualitative
results of findings and discussions. However, the aim of
the workshop was to represent a range of perspectives in
using PROMs in palliative and EOL care and in research,
thus the aims were achieved.
Conclusion
Outcome measurement must be based on rigorous science and
meet the complexity of patients' needs at the same time to
improve the quality of care of patients with advanced and life-
limiting diseases. The balance between the need of standard-
isation and diversity will be a challenge; however, consensus
building and multiprofessional developments and initiatives
will help us overcome these challenges.
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